Fabien Chevalier

Dr. Fabien Chevalier


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2016 in Trends in Molecular Medicine
Verified
Journal Article
Closed access
NCNatasha C. Chang
Natasha C. Chang
FCFabien Chevalier
Fabien Chevalier
MRMichael Rudnicki
Michael Rudnicki

1 May 2018 in Cell Stem Cell
Verified
Journal Article
Closed access
NCNatasha C. Chang
Natasha C. Chang
MSMarie-Claude Sincennes
Marie-Claude Sincennes
FCFabien Chevalier
Fabien Chevalier
CBCaroline E. Brun
Caroline E. Brun
MLMelanie Lacaria
Melanie Lacaria
MRMichael Rudnicki
Michael Rudnicki

1 May 2014 in Stem Cell Research
Verified
Journal Article
Open access
FCFabien Chevalier
Fabien Chevalier
MLMélanie Lavergne
Mélanie Lavergne
ENElisa Negroni
Elisa Negroni
SFSégolène Ferratge
Ségolène Ferratge
GCGilles Carpentier
Gilles Carpentier
PAPatricia Albanese
Patricia Albanese
Human circulating endothelial progenitor cells isolated from peripheral blood generate in culture cells with features of endothelial cells named late-outgrowth endothelial colony-forming cells (ECFC). In adult blood, ECFC display a constant quantitative and qualitative decline during life span. Even after expansion, it is difficult to reach the cell dose required for cell therapy of vascular diseases, thus limiting the clinical use of these cells. Glycosaminoglycans (GAG) are components from the extracellular matrix (ECM) that are able to interact and potentiate heparin binding growth factor (HBGF) activities. According to these relevant biological properties of GAG, we designed a GAG mimetic having the capacity to increase the yield of ECFC production from blood and to improve functionality of their endothelial outgrowth. We demonstrate that the addition of [OTR(4131)] mimetic during the isolation process of ECFC from Cord Blood induces a 3 fold increase in the number of colonies. Moreover, addition of [OTR(4131)] to cell culture media improves adhesion, proliferation, migration and self-renewal of ECFC. We provide evidence showing that GAG mimetics may have great interest for cell therapy applied to vascular regeneration therapy and represent an alternative to exogenous growth factor treatments to optimize potential therapeutic properties of ECFC.

2 March 2022 in Cells
Verified
Journal Article
Open access
PDF file
JRJulie Sandra Rorteau
Julie Sandra Rorteau
FCFabien Chevalier
Fabien Chevalier
SBSEBASTIEN BONNET
SEBASTIEN BONNET
TBThéo Barthélemy
Théo Barthélemy
ALAmandine Lopez-Gaydon
Amandine Lopez-Gaydon
JLJérôme Lamartine
Jérôme Lamartine
Chronological aging is defined as a time-dependent decline of tissue homeostasis which severely impacts skin. Understanding the mechanisms of skin aging is an active research area limited by the lack of relevant in vitro models. Being a component of aging, replicative or stress-induced senescence is repeatedly used to mimic skin aging in vitro, thus presenting only a partial view of the complexity of aging. Herein, we aimed to clarify whether primary normal human dermal fibroblasts retained age-related characteristics when cultured in 2D monolayer, and could be used as a relevant model for aging research. We compared three groups of fibroblasts isolated from different aged donors. We observed strongly decreased population doubling capacities, a reduced clonogenic ability, an impairment in extracellular matrix production together with modifications of respiratory metabolism with an increase in age. These disruptions were particularly marked when comparing fibroblasts isolated from old individuals (over 70 years old) to those isolated from young individuals (18–37 years old), while cells from middle-aged donors exhibited an intermediate profile. These alterations of cell features can be related to the signs of dermis aging, thus showing that cultured primary cells indeed retain some characteristics of the original tissue from which they were extracted.

1 August 2014 in Journal of Neuropathology & Experimental Neurology
Verified
Journal Article
Open access
PDF file
ENElisa Negroni
Elisa Negroni
EHEmilie Henault
Emilie Henault
FCFabien Chevalier
Fabien Chevalier
MGMarie Gilbert-Sirieix
Marie Gilbert-Sirieix
TKToin H. Van Kuppevelt
Toin H. Van Kuppevelt
PAPatricia Albanese
Patricia Albanese
Widespread skeletal muscle degeneration and impaired regeneration lead to progressive muscle weakness and premature death in patients with Duchenne mu

28 February 2022 in Cells
Verified
Journal Article
Open access
PDF file
FCFabien Chevalier
Fabien Chevalier
JRJulie Sandra Rorteau
Julie Sandra Rorteau
SFSandra Ferraro
Sandra Ferraro
LMLisa S. Martin
Lisa S. Martin
AGAlejandro Gonzalez-Torres
Alejandro Gonzalez-Torres
JLJérôme Lamartine
Jérôme Lamartine
Chronological aging is characterized by an alteration in the genes’ regulatory network. In human skin, epidermal keratinocytes fail to differentiate properly with aging, leading to the weakening of the epidermal function. MiR-30a is particularly overexpressed with epidermal aging, but the downstream molecular mechanisms are still uncovered. The aim of this study was to decipher the effects of miR-30a overexpression in the human epidermis, with a focus on keratinocyte differentiation. We formally identified the mitophagy receptor BNIP3L as a direct target of miR-30a. Using a 3D organotypic model of reconstructed human epidermis overexpressing miR-30a, we observed a strong reduction in BNIP3L expression in the granular layer. In human epidermal sections of skin biopsies from donors of different ages, we observed a similar pattern of BNIP3L decreasing with aging. Moreover, human primary keratinocytes undergoing differentiation in vitro also showed a decreased expression of BNIP3L with age, together with a retention of mitochondria. Moreover, aging is associated with altered mitochondrial metabolism in primary keratinocytes, including decreased ATP-linked respiration. Thus, miR-30a is a negative regulator of programmed mitophagy during keratinocytes terminal differentiation, impairing epidermal homeostasis with aging.